Skip to main content
SpringerLink
Log in
Book cover

Tumorerkrankungen der Vulva und Vagina pp 273–281Cite as

Melanom der Vagina

  • Chapter
  • First Online:

  • 1106 Accesses

Zusammenfassung

In vielen Arbeiten zur Inzidenz genitaler Melanome werden Vulvamelanome und vaginale Melanome zusammengefasst. Nach Daten des SEER-Programms (Surveillance, Epidemiology, and End Results) des National Cancer Institute liegt die Inzidenz der malignen Melanome der Vulva und Vagina in der kaukasischen Bevölkerung bei rund 0,1–0,2 Fälle pro 100.000 Einwohner pro Jahr. Dabei betreffen 1,3 % aller Melanomdiagnosen der Frau die Vulva und 0,3 % die Vagina (Weinstock 1994). Betroffene Patientinnen sind typischerweise zwischen 60 und 80 Jahre alt.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Abramova L, Parekh J, Irvin WP Jr, Rice LW, Taylor PT Jr, Anderson WA, Slingluff CL Jr (2002) Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review. Ann Surg Oncol 9(9):840–846

    Article  PubMed  Google Scholar 

  • Buchanan DJ, Schlaerth J, Kurosaki T (1998) Primary vaginal melanoma: thirteen-year disease-free survival after wide local excision and review of recent literature. Am J Obstet Gynecol 178(6):1177–1184

    Article  CAS  PubMed  Google Scholar 

  • Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, Panageas KS, Busam KJ, Chmielowski B, Lutzky J, Pavlick AC, Fusco A, Cane L, Takebe N, Vemula S, Bouvier N, Bastian BC, Schwartz GK (2011) Kit as a therapeutic target in metastatic melanoma. JAMA 305(22):2327–2334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chanal J, Kramkimel N, Guegan S, Moguelet P, Fourchotte V, Avril MF (2016) Locally advanced unresectable vaginal melanoma: response with anti-programmed death receptor 1. J Low Genit Tract Dis 20(1):e4–e5

    Article  PubMed  Google Scholar 

  • Chung AF, Woodruff JM, Lewis JL Jr (1975) Malignant melanoma of the vulva: a report of 44 cases. Obstet Gynecol 45(6):638–646

    Article  CAS  PubMed  Google Scholar 

  • D’Angelo SP, Larkin J, Sosman JA, Lebbe C, Brady B, Neyns B, Schmidt H, Hassel JC, Hodi FS, Lorigan P, Savage KJ, Miller WH Jr, Mohr P, Marquez-Rodas I, Charles J, Kaatz M, Sznol M, Weber JS, Shoushtari AN, Ruisi M, Jiang J, Wolchok JD (2017) Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol 35(2):226–235

    Article  PubMed  Google Scholar 

  • Dhar KK, Das N, Brinkman DA, Beynon JL, Woolas RP (2007) Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature. Int J Gynecol Cancer 17(3):720–723

    Article  CAS  PubMed  Google Scholar 

  • Douglas JG, Margolin K (2002) The treatment of brain metastases from malignant melanoma. Semin Oncol 29(5):518–524

    Article  PubMed  Google Scholar 

  • Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, Bostroem A, Heese O, Koelbl O, Garbe C, Schadendorf D (2011) Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 117(8):1697–1703

    Article  Google Scholar 

  • Eigentler TK, Muhlenbein C, Follmann M, Schadendorf D, Garbe C (2017) S3-leitlinie Diagnostik, Therapie und Nachsorge des Melanoms, Update 2015/2016, Kurzversion 2.0. J Dtsch Dermatol Ges 15(6):e1–e41

    Article  PubMed  Google Scholar 

  • Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters M, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 376(23):2211–2222

    Article  PubMed  PubMed Central  Google Scholar 

  • Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF (2008) Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 108(3):478–481

    Article  PubMed  Google Scholar 

  • Gökaslan H, Şişmanoğlu A, Pekin T, Kaya H, Ceyhan N (2005) Primary malignant melanoma of the vagina: a case report and review of the current treatment options. Eur J Obst Gynecol Reprod Biol 121(2):243–248

    Article  Google Scholar 

  • Guo J, Si L, Kong Y, Flaherty KT, Xu X, Zhu Y, Corless CL, Li L, Li H, Sheng X, Cui C, Chi Z, Li S, Han M, Mao L, Lin X, Du N, Zhang X, Li J, Wang B, Qin S (2011) Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-kit mutation or amplification. J Clin Oncol 29(21):2904–2909

    Article  CAS  PubMed  Google Scholar 

  • Heinzelmann-Schwarz VA, Nixdorf S, Valadan M, Diczbalis M, Olivier J, Otton G, Fedier A, Hacker NF, Scurry JP (2014) A clinicopathological review of 33 patients with vulvar melanoma identifies c-kit as a prognostic marker. Int J Mol Med 33(4):784–794

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hou JY, Baptiste C, Hombalegowda RB, Tergas AI, Feldman R, Jones NL, Chatterjee-Paer S, Bus-Kwolfski A, Wright JD, Burke WM (2017) Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma. Cancer 123(8):1333–1344

    Article  CAS  PubMed  Google Scholar 

  • Leitao MM Jr (2014) Management of vulvar and vaginal melanomas: current and future strategies. Am Soc Clin Oncol Educ Book e277–e281

    Google Scholar 

  • Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, Sunderkotter C, Kaatz M, Schulte KW, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Martus P, Garbe C (2016) Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (decog-slt): a multicentre, randomised, phase 3 trial. Lancet Oncol 17(6):757–767

    Article  PubMed  Google Scholar 

  • Lens MB, Dawes M, Goodacre T, Newton-Bishop JA (2002) Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials. Arch Surg 137(4):458–461

    Article  PubMed  Google Scholar 

  • Leo F, Cagini L, Rocmans P, Cappello M, Geel AN, Maggi G, Goldstraw P, Pastorino U (2000) Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer 83(5):569–572

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miner TJ, Delgado R, Zeisler J, Busam K, Alektiar K, Barakat R, Poynor E (2004) Primary vaginal melanoma: a critical analysis of therapy. Ann Surg Oncol 11(1):34–39

    Article  PubMed  Google Scholar 

  • Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH (1991) Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 214(4): 491–499 (discussion 499–501)

    Google Scholar 

  • Nakagawa S, Koga K, Kugu K, Tsutsumi O, Taketani Y (2002) The evaluation of the sentinel node successfully conducted in a case of malignant melanoma of the vagina. Gynecol Oncol 86(3):387–389

    Article  PubMed  Google Scholar 

  • Omholt K, Grafstrom E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK (2011) Kit pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res 17(12):3933–3942

    Article  CAS  PubMed  Google Scholar 

  • Petru E, Nagele F, Czerwenka K, Graf AH, Lax S, Bauer M, Pehamberger H, Vavra N (1998) Primary malignant melanoma of the vagina: long-term remission following radiation therapy. Gynecol Oncol 70(1):23–26

    Article  CAS  PubMed  Google Scholar 

  • Piura B (2008) Management of primary melanoma of the female urogenital tract. Lancet Oncol 9(10):973–981

    Article  PubMed  Google Scholar 

  • Piura B, Rabinovich A, Yanai-Inbar I (2002) Primary malignant melanoma of the vagina: case report and review of literature. Eur J Gynaecol Oncol 23(3):195–198

    PubMed  CAS  Google Scholar 

  • Podratz KC, Gaffey TA, Symmonds RE, Johansen KL, O’Brien PC (1983) Melanoma of the vulva: an update. Gynecol Oncol 16(2):153–168

    Article  CAS  PubMed  Google Scholar 

  • Raigani S, Cohen S, Boland GM (2017) The role of surgery for melanoma in an era of effective systemic therapy. Curr Oncol Rep 19(3):17

    Article  PubMed  Google Scholar 

  • Rate WR, Solin LJ, Turrisi AT (1988) Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression. Int J Radiat Oncol Biol Phys 15(4):859–864

    Article  CAS  PubMed  Google Scholar 

  • Seegenschmiedt MH, Keilholz L, Pieritz A, Altendorf-Hofmann A, Urban A, Schell H, Hohenberger W, Sauer R (1999) Locally recurrent and metastatic malignant melanoma. Long-term results and prognostic factors after percutaneous radiotherapy. Strahlenther Onkol 175(9):450–457

    Article  CAS  PubMed  Google Scholar 

  • Stevens G, McKay MJ (2006) Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma. Lancet Oncol 7(7):575–583

    Article  PubMed  Google Scholar 

  • Tacastacas JD, Bray J, Cohen YK, Arbesman J, Kim J, Koon HB, Honda K, Cooper KD, Gerstenblith MR (2014) Update on primary mucosal melanoma. J Am Acad Dermatol 71(2):366–375

    Article  PubMed  Google Scholar 

  • Tcheung WJ, Selim MA, Herndon JE 2nd, Abernethy AP, Nelson KC (2012) Clinicopathologic study of 85 cases of melanoma of the female genitalia. J Am Acad Dermatol 67(4):598–605

    Article  PubMed  Google Scholar 

  • Weinstock MA (1994) Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 171(5):1225–1230

    Article  CAS  PubMed  Google Scholar 

  • Zambo K, Szabo Z, Schmidt E, Koppan M, Repasy I, Bodis J (2007) Is the clinical staging system a good choice in the staging of vulvar malignancies? Eur J Nucl Med Mol Imaging 34(11): 1878–1879 (author reply 1880)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Hautklinik, Tübingen, Deutschland

    Thomas Eigentler

Authors
  1. Thomas Eigentler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Eigentler .

Editor information

Editors and Affiliations

  1. Kaarst, Germany

    Hans-Georg Schnürch

  2. Frauenklinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany

    Monika Hampl

  3. Klinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

    Linn Wölber

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Eigentler, T. (2018). Melanom der Vagina. In: Schnürch, HG., Hampl, M., Wölber, L. (eds) Tumorerkrankungen der Vulva und Vagina. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-56636-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-56636-7_10

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-56635-0

  • Online ISBN: 978-3-662-56636-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation